Rbin Laboratories Private Limited
About Rbin Laboratories Private Limited
Data last updated:
Rbin Laboratories Private Limited is a private limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24119BR2018PTC039044. Its GSTIN is 10AAJCR1067N1ZB (Bihar).
The company has an authorised share capital of ₹95 Lakh and a paid-up capital of ₹60.1 Lakh. It was formerly known as Ravian Laboratories Private Limited. It is led by directors Binita Mishra and Sandeep Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 5 To 11 Sri Ram Tower Main Road Kankarbagh, Patna, Bihar, India – 800020.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.93 Lakh, a decline of 92% compared to the previous year. For the same year it recorded a net loss of ₹74.09 Lakh (net margin -437.5%) and EBITDA of -₹73.82 Lakh (EBITDA margin -436%). Revenue has declined at a compounded annual rate (CAGR) of 60% over three years and 27% over five years.
The company has about 14 employees on its provident fund (EPFO) records.
Company details
Contact details
Rbin Laboratories Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 5 To 11 Sri Ram Tower Main Road Kankarbagh, Patna, Bihar, India – 800020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rbin Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rbin Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rbin Laboratories Private Limited, buy the company report.
Financials of Rbin Laboratories Private Limited
FY 2025 filings availableRbin Laboratories Private Limited reported revenue of ₹16.93 Lakh (down 92% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 27% over five years, including a 92% fall in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹73.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹74.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -436% | ||||
| Net Profit Margin | -437.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rbin Laboratories Private Limited, buy the company report.
Board of directors of Rbin Laboratories Private Limited
Rbin Laboratories has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Binita Mishra Also directs: Skyline Villa Limited | Director | 11 Sep 2018 | 8 Years 1 Months | Current |
| Sandeep Kumar Srivastava | Director | 11 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Rbin Laboratories Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lamcy Pharmaceuticals Private Limited | ₹16.95 Lakh (FY 2015) | 8.0% | Bengaluru, Karnataka, India | |||
| Sardana Innovation Private Limited | ₹16.94 Lakh (FY 2021) | Hisar, Haryana, India | ||||
| Mgtrends Private Limited | ₹16.94 Lakh (FY 2024) | -92.0% | Hyderabad, Telangana, India | |||
| Shupar Packaging Private Limited | ₹16.94 Lakh (FY 2024) | Pune, Maharashtra, India | ||||
| Incubator Ecom Private Limited | ₹16.94 Lakh (FY 2025) | 632.0% | New Delhi, Delhi, India | |||
| Rbin Laboratories Private Limitedthis company | ₹16.93 Lakh (FY 2024) | -₹74.09 Lakh | -437.5% | -92.0% | 14 | Patna, Bihar, India |
| T.G.Creation Private Limited | ₹16.93 Lakh (FY 2024) | -48.0% | Kolkata, West Bengal, India | |||
| Mangal Energy and Power Private Limited | ₹16.93 Lakh (FY 2025) | -75.0% | Hyderabad, Telangana, India | |||
| Life Care Health Casa Private Limited | ₹16.93 Lakh (FY 2025) | 886.0% | Kangra, Himachal Pradesh, India | |||
| Shree Chaturbhuj International Private Limited | ₹16.93 Lakh (FY 2025) | 187.0% | Uttar Pradesh, India | |||
| Drona Adhesives Private Limited | ₹16.93 Lakh (FY 2025) | 59.0% | New Delhi, Delhi, India |
To see the full peer comparison of Rbin Laboratories Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rbin Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rbin Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rbin Laboratories Private Limited has a workforce of 14 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Rbin Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAJCR1067N1ZB | Bihar | Active | 04 Oct 2018 |
To see the full GST registrations and return filing status of Rbin Laboratories Private Limited, buy the company report.
Recent activity
Rbin Laboratories Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Anil Kumar Shahi ceased to be Director on 13 Sep 2018.
Frequently asked questions
Rbin Laboratories is an active private limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 August 2018 (8+ years old) and is registered under CIN U24119BR2018PTC039044.
Rbin Laboratories has 2 current directors:
- Binita Mishra - Director
- Sandeep Kumar Srivastava - Director
The latest financial statements of Rbin Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Rbin Laboratories is 10AAJCR1067N1ZB, registered in Bihar.
The CIN (Corporate Identification Number) of Rbin Laboratories is U24119BR2018PTC039044. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rbin Laboratories was incorporated on 30 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Rbin Laboratories by revenue are Lamcy Pharmaceuticals Private Limited, Sardana Innovation Private Limited, Mgtrends Private Limited, Shupar Packaging Private Limited, Incubator Ecom Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Anil Kumar Shahi ceased to be Director on 13 Sep 2018. Rakesh Mishra ceased to be Director on 13 Sep 2018. Binita Mishra was appointed as Director on 11 Sep 2018. Rbin Laboratories has 4 board changes on record in total.
The registered office of Rbin Laboratories is at Shop No. 5 To 11 Sri Ram Tower Main Road Kankarbagh, Patna, Bihar, India – 800020.
Rbin Laboratories operates in the pharma industry, in the drug formulation and development segment.
Yes. Rbin Laboratories was formerly known as Ravian Laboratories Private Limited.